Developing robotic add-ons to help doctors control endoscopic instruments
Interventional endoscopy requires doctors to manoeuvre a flexible scope while inserting instruments through its working channel. Loss of target visibility, poor precision control and workflow interruptions make these procedures demanding and add to clinicians' cognitive workload.
AIDO is developing a robotic add-on for existing endoscopes to assist complex procedures in digestive cancer care. Its modular hardware and software are designed to help doctors control instruments passed through the endoscope.
What stands out about AIDO
NLC introduced AIDO as its venture, developing instrument-control assistance for physicians performing endoscopic procedures.
Supported by 21st by CentraleSupélec while developing its robotic endoscopy assistant at the proof-of-concept stage.
CEO Charlotte Cavé previously held leadership roles at Boston Scientific.
CEO Charlotte Cavé also brings prior Medtronic experience.
Charlotte Cavé founded Accelerating Medical Devices; Helena Grinberg-Rashi founded Titania Technologies, both before AIDO.
AIDO is featured in the Quest for change incubator network, which supports startups through a structured incubation methodology.
NLC reported AIDO usability research with more than 60 expert and novice endoscopists in 2022, assessing its concept and design.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.